BAKER Bros. Advisors L.P., 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 68,298 shares at $5.74 ($396K) on 2022-05-24, disclosed to the SEC on 2022-05-24.
Open-market purchase of $396k TRDA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.84 | 946 | $6K | 1.4% |
| 2 | $5.84 | 883 | $5K | 1.3% |
| 3 | $5.84 | 7,248 | $42K | 10.7% |
| 4 | $5.84 | 7,772 | $45K | 11.5% |
| 5 | $5.99 | 7,010 | $42K | 10.6% |
| 6 | $5.99 | 827 |
| $5K |
| 1.3% |
| 7 | $5.74 | 2,334 | $13K | 3.4% |
| 8 | $5.74 | 19,789 | $114K | 28.7% |
| 9 | $5.74 | 19,789 | $114K | 28.7% |
| 10 | $5.93 | 179 | $1K | 0.3% |
| 11 | $5.93 | 1,521 | $9K | 2.3% |
| Total | $5.80 avg | 68,298 | $396K | 100% |
| Filing → |
| IGMS | BUY | 2024-03-28 | $6.8M | — | Filing → |
| MDGL | BUY | 2023-12-14 | $45.0M | — | Filing → |
| TRDA | BUY | 2022-05-18 | $631K | — | Filing → |